BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Mafenide

A sulfonamide that inhibits the enzyme CARBONIC ANHYDRASE and is used as a topical anti-bacterial agent, especially in burn therapy.

169+ PubMed studies analyzed · 1 RCTs · Evidence Score: 43.9

Research Domains

Mafenide has been studied across 12 research domains including ✨ Skin & Hair, 🧠 Focus & Attention, 🦴 Bone & Joint, 🔬 Inflammation, 🔬 Oncology. The primary research focus is ✨ Skin & Hair with 26% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Mafenide, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

benzolamide
10 shared targets
Sulfanilamide
11 shared targets
Chlorthalidone
9 shared targets
Zonisamide
10 shared targets
Metolazone
9 shared targets
veratric
7 shared targets
24
7 shared targets
trichlormethiazide
7 shared targets
Indapamide
9 shared targets
trientine
7 shared targets
Loading evidence profile...

This evidence profile for Mafenide is generated deterministically from 169 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.